Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC

A Corrigendum to this article was published on 05 March 2013

Abstract

The Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC) highlighted 81 single-nucleotide polymorphisms (SNPs) with moderate evidence for association to schizophrenia. After follow-up in independent samples, seven loci attained genome-wide significance (GWS), but multi-locus tests suggested some SNPs that did not do so represented true associations. We tested 78 of the 81 SNPs in 2640 individuals with a clinical diagnosis of schizophrenia attending a clozapine clinic (CLOZUK), 2504 cases with a research diagnosis of bipolar disorder, and 2878 controls. In CLOZUK, we obtained significant replication to the PGC-associated allele for no fewer than 37 (47%) of the SNPs, including many prior GWS major histocompatibility complex (MHC) SNPs as well as 3/6 non-MHC SNPs for which we had data that were reported as GWS by the PGC. After combining the new schizophrenia data with those of the PGC, variants at three loci (ITIH3/4, CACNA1C and SDCCAG8) that had not previously been GWS in schizophrenia attained that level of support. In bipolar disorder, we also obtained significant evidence for association for 21% of the alleles that had been associated with schizophrenia in the PGC. Our study independently confirms association to three loci previously reported to be GWS in schizophrenia, and identifies the first GWS evidence in schizophrenia for a further three loci. Given the number of independent replications and the power of our sample, we estimate 98% (confidence interval (CI) 78–100%) of the original set of 78 SNPs represent true associations. We also provide strong evidence for overlap in genetic risk between schizophrenia and bipolar disorder.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McGrath JJ . The surprisingly rich contours of schizophrenia epidemiology. Arch Gen Psychiatry 2007; 64: 14–16.

    PubMed  Google Scholar 

  2. Harrison PJ . The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122 (Part 4): 593–624.

    Article  PubMed  Google Scholar 

  3. Cardno AG, Gottesman II . Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 2000; 97: 12–17.

    Article  CAS  PubMed  Google Scholar 

  4. Sullivan PF, Kendler KS, Neale MC . Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187–1192.

    PubMed  Google Scholar 

  5. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969–976.

    Article  CAS  Google Scholar 

  6. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–752.

    CAS  PubMed  Google Scholar 

  7. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008; 40: 1053–1055.

    Article  CAS  PubMed  Google Scholar 

  8. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744–747.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753–757.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Rietschel M, Mattheisen M, Degenhardt F, Kahn RS, Linszen DH, Os JV et al. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry; advance online publication, 12 July 2011.

  11. Sebat J, Levy DL, McCarthy SE . Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 2009; 25: 528–535.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142–153.

    Article  CAS  PubMed  Google Scholar 

  13. Gottesman I . Schizophrenia Genesis: The Origins of Madness. WH Freeman: New York, 1991.

    Google Scholar 

  14. Ekholm B, Ekholm A, Adolfsson R, Vares M, Osby U, Sedvall GC et al. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry 2005; 59: 457–464.

    Article  PubMed  Google Scholar 

  15. Jakobsen KD, Frederiksen JN, Hansen T, Jansson LB, Parnas J, Werge T . Reliability of clinical ICD-10 schizophrenia diagnoses. Nord J Psychiatry 2005; 59: 209–212.

    Article  PubMed  Google Scholar 

  16. Coentre R, Blanco P, Fontes S, Power P . Initial diagnosis and treatment in first-episode psychosis: can an operationalized diagnostic classification system enhance treating clinicians' diagnosis and the treatment chosen? Early Interv Psychiatry 2011; 5: 132–139.

    Article  PubMed  Google Scholar 

  17. Strange A, Riley BP, Spencer CCA, Morris DW, Brinen M, O'Dushlaine CT et al. Genome-wide association study implicates HLA-C*01:02 as a risk factor at the MHC locus in schizophrenia. Biol Psychiatry 2012 (in press).

  18. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661–678.

    Article  Google Scholar 

  19. Steinberg S, de Jong S, Andreassen OA, Werge T, Borglum AD, Mors O et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 2011; 20: 4076–4081.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Williams HJ, Craddock N, Russo G, Hamshere ML, Moskvina V, Dwyer S et al. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet 2011; 20: 387–391.

    Article  CAS  PubMed  Google Scholar 

  21. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056–1058.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, Detera-Wadleigh SD et al. Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet 2010; 42: 128–131.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977–983.

    Article  CAS  PubMed Central  Google Scholar 

  24. Otto EA, Hurd TW, Airik R, Chaki M, Zhou W, Stoetzel C et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat Genet 2010; 42: 840–850.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Hildebrandt F, Attanasio M, Otto E . Nephronophthisis: disease mechanisms of a ciliopathy. J Am Soc Nephrol 2009; 20: 23–35.

    Article  CAS  PubMed  Google Scholar 

  26. Ingason A, Giegling I, Cichon S, Hansen T, Rasmussen HB, Nielsen J et al. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet 2010; 19: 1379–1386.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E et al. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 2009; 14: 252–260.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the participants in this study and Novartis for their guidance and co-operation in obtaining CLOZUK. We also thank staff at The Doctor's Laboratory, in particular Lisa Levett and Andrew Levett, for help and advice regarding sample acquisition. We acknowledge Kiran Mantripragada, Lesley Bates, Catherine Bresner and Lucinda Hopkins for laboratory sample management, and Dobril Ivanov for computing support. Sample collection and analysis was supported by the following grants: Medical Research Council (MRC) Centre (G0800509) and Program Grant (G0801418), the Wellcome Trust (WT; 078901), the European Community's Seventh Framework Programme (HEALTH-F2-2010-241909 (Project EU-GEI)), the Stanley Medical Research Institute via the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard, and by CONTE NIMH (5P50MH066392-09). Genotyping was supported by the WT under WTCCC+ (Bipolar and controls) and WTCCC2. We thank the WTCCC2 project funded by WT (083948/Z/07/Z) for making available the control data. We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the MRC (G0000934) and the WT (068545/Z/0), the UK Blood Services collection of Common Controls (UKBS-CC collection), funded by the WT (076113/C/04/Z) and by NIHR programme grant to NHSBT (RP-PG-0310-1002).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding authors

Correspondence to M J Owen or M C O'Donovan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamshere, M., Walters, J., Smith, R. et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry 18, 708–712 (2013). https://doi.org/10.1038/mp.2012.67

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2012.67

Keywords

This article is cited by

Search

Quick links